α-2,3-sialyltransferase type 3N and α-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma

Cancer

Volumn 79, Issue 9, 1997, Pages 1678-1685

  Ogawa, Jun Ichi ^a,b   Lnoue, Hiroshi ^a   Koide, Shirosaku ^a  

^a TOKAI UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

1,3 fucosyltransferase; 2,3 sialyltransferase; lung neoplasms; sialyl Lewis(x)

Indexed keywords

DNA; FUCOSYLTRANSFERASE; SIALYLTRANSFERASE; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARBOHYDRATE SYNTHESIS; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SIALYLATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FUCOSYLTRANSFERASES; GENE AMPLIFICATION; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGOSACCHARIDES; PROGNOSIS; SIALYLTRANSFERASES; STAINING AND LABELING; SURVIVAL ANALYSIS;

EID: 0030990148     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970501)79:9<1678::AID-CNCR7>3.0.CO;2-8     Document Type: Article

References (28)

1. x. Science 1990; 250:1130-2.
2. x determinant on myeloid and tumor cells. Science 1990; 250:1132-5.
3. Tyrrell D, James P, Rao N, Foxall C, Abbas S, Dasgupta F, et al. Structural requirement for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci U S A 1991; 88:10372-6.
4. Tiemeyer M, Swiedler SJ, Ishihara M, Moreland M, Schweingruber H, Hirtzer P, et al. Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 1991; 88:1138-42.
5. Nelson RM, Dolich S, Aruffo A, Cecconi O, Bevilaqua MP. Higher-affinity oligosaccharide ligands for E-selectin. J Clin Invest 1993; 91:1157-66.
6. x and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Cancer 1994; 73:1177-83.
7. 6) in human lung carcinoma PC9 cells. J Biol Chem 1986; 261:3737-43.
8. Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α (1,3/1,4) fucosyltransferase. Genes Dev 1990; 4:1288-303.
9. Goelz SE, Hession C, Goff D, Griffiths B, Tizard R, Newman B, et al. ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell 1990; 63:1349-56.
10. Weston BW, Nair RP, Larsen RD, Lowe JB. Isolation of a novel human a (1,3) fucosyltransferase gene and molecular comparison to the human Lewis blood group α (1,3/1,4) fucosyltransferase gene. J Biol Chem 1992; 267:4152-60.
11. Weston BW, Smith PL, Kelly RJ, Lowe JB. Molecular cloning of a fourth member of a human α (1,3) fucosyltransferase gene family. J Biol Chem 1992; 267:24575-84.
12. Sasaki K, Kurata K, Funayama K, Nagata M, Watanabe E, Ohta S, et al. Expression cloning of a novel α 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem 1994; 269:14730-7.
13. Grundmann U, Nerlich C, Rein T, Zettlmeissl G. Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res 1990; 18:667.
14. Kitagawa H, Paulson JC. Cloning and expression of human Gal β1,3(4) GlcNAc α 2,3-sialyltransferase. Biochem Biophys Res Commun 1993; 194:375-82.
15. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 1994; 269:17872-8.
16. Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, et al. Expression cloning of a novel Gal β(1-3/1-4) GlcNAc α 2,3-sialyltransferase using lectin resistance selection. J Biol Chem 1993; 268:22782-7.
17. Kitagawa H, Paulson JC. Cloning of a novel α 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem 1994; 269:1394-401.
18. Mollicone R, Gibaud A, Francois A, Ratcliffe M, Oriol R. Acceptor specificity and tissue distribution of three human α-3-fucosyltransferases. Eur J Biochem 1990; 191:169-76.
19. Majuri ML, Niemela R, Tiisala S, Renkonen O, Renkonen R. Expression and function of α 2,3-sialyl- and α 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int J Cancer 1995; 63:551-9.
20. American Joint Committee on Cancer. Manual for staging of cancer. In: Lung. 4th edition. Philadelphia: JB Lippincott, 1992:115-22.
21. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985; 130:118-26.
22. Ogawa J, lnoue H, Koide S. Expression of α-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 1996; 56:325-9.
23. Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, et al. The human β2-microglobulin gene primary structure and definition of the transcriptional unit. J Immunol 1987; 139:3132-8.
24. Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1994; 269:1425-31.
25. x antigen in relation to survival of patients with colorectal carcinoma. Cancer 1993; 72:2323-30.
26. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 1993; 53:3632-7.
27. Miyamoto D, Takashima S, Suzuki T, Nishi T, Sasaki K, Morishita Y, et al. Glycolipid acceptor specificity of a human Gal β (1-3/1-4) GlcNAc α 2,3-sialyltransferase. Biochem Biophys Res Commun 1995; 217:852-8.
28. Kitagawa H, Mattei MG, Paulson JC. Genomic organization and chromosomal mapping of the Gal β 1,3GalNAc/Gal β 1,4GlcNAc α 2,3-sialyltransferase. J Biol Chem 1996; 271:931-8.